MedTrace Logo

Effect of Hemodialysis Membranes on Platelet Count

NCT01356576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2014-02-07

No results posted yet for this study

Summary

The purpose of this study is to determine if there is a drop in platelet count after hemodialysis. Hemodialysis membranes are known to activate complement and cause a drop in platelets and sometimes in white blood cells. The investigators are going to study one of the membranes which is the Fresenius Optiflux® to check if it causes a drop in platelets.

Conditions

Sponsors & Collaborators

  • Staten Island University Hospital

    collaborator OTHER

  • Northwell Health

    lead OTHER

Principal Investigators

  • Edwerd Epstein, M.D. · Staten Island University Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01356576 on ClinicalTrials.gov